Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS? / Østergaard, Mikkel; Conaghan, Philip G; O'Connor, Philip; Szkudlarek, Marcin; Klarlund, Mette; Emery, Paul; Peterfy, Charles; Genant, Harry; McQueen, Fiona M; Bird, Paul; Lassere, Marissa; Ejbjerg, Bo; Ostergaard, Mikkel; Conaghan, Philip G; O'Connor, Philip; Szkudlarek, Marcin; Klarlund, Mette; Emery, Paul; Peterfy, Charles; Genant, Harry; McQueen, Fiona M; Bird, Paul; Lassere, Marissa; Ejbjerg, Bo.

In: Journal of Rheumatology, Vol. 36, No. 8, 2009, p. 1806-10.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Østergaard, M, Conaghan, PG, O'Connor, P, Szkudlarek, M, Klarlund, M, Emery, P, Peterfy, C, Genant, H, McQueen, FM, Bird, P, Lassere, M, Ejbjerg, B, Ostergaard, M, Conaghan, PG, O'Connor, P, Szkudlarek, M, Klarlund, M, Emery, P, Peterfy, C, Genant, H, McQueen, FM, Bird, P, Lassere, M & Ejbjerg, B 2009, 'Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?', Journal of Rheumatology, vol. 36, no. 8, pp. 1806-10. https://doi.org/10.3899/jrheum.090350, https://doi.org/10.3899/jrheum.090350

APA

Østergaard, M., Conaghan, P. G., O'Connor, P., Szkudlarek, M., Klarlund, M., Emery, P., Peterfy, C., Genant, H., McQueen, F. M., Bird, P., Lassere, M., Ejbjerg, B., Ostergaard, M., Conaghan, P. G., O'Connor, P., Szkudlarek, M., Klarlund, M., Emery, P., Peterfy, C., ... Ejbjerg, B. (2009). Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS? Journal of Rheumatology, 36(8), 1806-10. https://doi.org/10.3899/jrheum.090350, https://doi.org/10.3899/jrheum.090350

Vancouver

Østergaard M, Conaghan PG, O'Connor P, Szkudlarek M, Klarlund M, Emery P et al. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS? Journal of Rheumatology. 2009;36(8):1806-10. https://doi.org/10.3899/jrheum.090350, https://doi.org/10.3899/jrheum.090350

Author

Østergaard, Mikkel ; Conaghan, Philip G ; O'Connor, Philip ; Szkudlarek, Marcin ; Klarlund, Mette ; Emery, Paul ; Peterfy, Charles ; Genant, Harry ; McQueen, Fiona M ; Bird, Paul ; Lassere, Marissa ; Ejbjerg, Bo ; Ostergaard, Mikkel ; Conaghan, Philip G ; O'Connor, Philip ; Szkudlarek, Marcin ; Klarlund, Mette ; Emery, Paul ; Peterfy, Charles ; Genant, Harry ; McQueen, Fiona M ; Bird, Paul ; Lassere, Marissa ; Ejbjerg, Bo. / Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?. In: Journal of Rheumatology. 2009 ; Vol. 36, No. 8. pp. 1806-10.

Bibtex

@article{6c49643085b811df928f000ea68e967b,
title = "Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?",
abstract = "OBJECTIVE: Gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) provides highly sensitive assessment of inflammatory and destructive changes in rheumatoid arthritis (RA) joints, but intravenous (IV) Gd injection prolongs examination time and increases cost, invasiveness, and patient discomfort. We explored to what extent RA joint pathologies in wrists and metacarpophalangeal (MCP) joints can be reliably assessed by unenhanced MRI images compared with Gd-enhanced MRI as the reference method. METHODS: MRI data sets from 2 RA substudies were scored according to preliminary OMERACT RA MRI scoring system (RAMRIS): Substudy A included 1.0 T/1.5 T MR images from 40 RA patients, which were scored twice by 2 experienced readers. Substudy B included 0.2 T dedicated extremity MRI (E-MRI) images from 55 patients, scored twice by one experienced reader. The first reading included only unenhanced images, whereas complete image sets were available for the second reading. RESULTS: Gd contrast injection appeared unimportant to MRI scores of bone erosions and bone edema in RA wrist and MCP joints. However, when post-Gd MRI was considered the standard reference, MRI without Gd provided only moderate to high agreement concerning assessment of synovitis, and omitting the post-Gd acquisitions increased the interreader variation on synovitis scores. Low-field (0.2 T) E-MRI in these exercises provided a lower sensitivity of unenhanced imaging for synovitis than MRI using higher-field strengths. CONCLUSION: Omitting IV contrast injection did not change scores of bone erosions and bone edema, but decreased the reliability of synovitis scores. However, this disadvantage may for some purposes be outweighed by the possibility to assess more joints and/or greater feasibility.",
author = "Mikkel {\O}stergaard and Conaghan, {Philip G} and Philip O'Connor and Marcin Szkudlarek and Mette Klarlund and Paul Emery and Charles Peterfy and Harry Genant and McQueen, {Fiona M} and Paul Bird and Marissa Lassere and Bo Ejbjerg and Mikkel Ostergaard and Conaghan, {Philip G} and Philip O'Connor and Marcin Szkudlarek and Mette Klarlund and Paul Emery and Charles Peterfy and Harry Genant and McQueen, {Fiona M} and Paul Bird and Marissa Lassere and Bo Ejbjerg",
note = "Keywords: Arthritis, Rheumatoid; Contrast Media; Cost Savings; Databases, Factual; Gadolinium; Humans; Magnetic Resonance Imaging; Metacarpophalangeal Joint; Reference Standards; Reproducibility of Results; Wrist Joint",
year = "2009",
doi = "10.3899/jrheum.090350",
language = "English",
volume = "36",
pages = "1806--10",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology Publishing Co. Ltd.",
number = "8",

}

RIS

TY - JOUR

T1 - Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?

AU - Østergaard, Mikkel

AU - Conaghan, Philip G

AU - O'Connor, Philip

AU - Szkudlarek, Marcin

AU - Klarlund, Mette

AU - Emery, Paul

AU - Peterfy, Charles

AU - Genant, Harry

AU - McQueen, Fiona M

AU - Bird, Paul

AU - Lassere, Marissa

AU - Ejbjerg, Bo

AU - Ostergaard, Mikkel

AU - Conaghan, Philip G

AU - O'Connor, Philip

AU - Szkudlarek, Marcin

AU - Klarlund, Mette

AU - Emery, Paul

AU - Peterfy, Charles

AU - Genant, Harry

AU - McQueen, Fiona M

AU - Bird, Paul

AU - Lassere, Marissa

AU - Ejbjerg, Bo

N1 - Keywords: Arthritis, Rheumatoid; Contrast Media; Cost Savings; Databases, Factual; Gadolinium; Humans; Magnetic Resonance Imaging; Metacarpophalangeal Joint; Reference Standards; Reproducibility of Results; Wrist Joint

PY - 2009

Y1 - 2009

N2 - OBJECTIVE: Gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) provides highly sensitive assessment of inflammatory and destructive changes in rheumatoid arthritis (RA) joints, but intravenous (IV) Gd injection prolongs examination time and increases cost, invasiveness, and patient discomfort. We explored to what extent RA joint pathologies in wrists and metacarpophalangeal (MCP) joints can be reliably assessed by unenhanced MRI images compared with Gd-enhanced MRI as the reference method. METHODS: MRI data sets from 2 RA substudies were scored according to preliminary OMERACT RA MRI scoring system (RAMRIS): Substudy A included 1.0 T/1.5 T MR images from 40 RA patients, which were scored twice by 2 experienced readers. Substudy B included 0.2 T dedicated extremity MRI (E-MRI) images from 55 patients, scored twice by one experienced reader. The first reading included only unenhanced images, whereas complete image sets were available for the second reading. RESULTS: Gd contrast injection appeared unimportant to MRI scores of bone erosions and bone edema in RA wrist and MCP joints. However, when post-Gd MRI was considered the standard reference, MRI without Gd provided only moderate to high agreement concerning assessment of synovitis, and omitting the post-Gd acquisitions increased the interreader variation on synovitis scores. Low-field (0.2 T) E-MRI in these exercises provided a lower sensitivity of unenhanced imaging for synovitis than MRI using higher-field strengths. CONCLUSION: Omitting IV contrast injection did not change scores of bone erosions and bone edema, but decreased the reliability of synovitis scores. However, this disadvantage may for some purposes be outweighed by the possibility to assess more joints and/or greater feasibility.

AB - OBJECTIVE: Gadolinium (Gd)-enhanced magnetic resonance imaging (MRI) provides highly sensitive assessment of inflammatory and destructive changes in rheumatoid arthritis (RA) joints, but intravenous (IV) Gd injection prolongs examination time and increases cost, invasiveness, and patient discomfort. We explored to what extent RA joint pathologies in wrists and metacarpophalangeal (MCP) joints can be reliably assessed by unenhanced MRI images compared with Gd-enhanced MRI as the reference method. METHODS: MRI data sets from 2 RA substudies were scored according to preliminary OMERACT RA MRI scoring system (RAMRIS): Substudy A included 1.0 T/1.5 T MR images from 40 RA patients, which were scored twice by 2 experienced readers. Substudy B included 0.2 T dedicated extremity MRI (E-MRI) images from 55 patients, scored twice by one experienced reader. The first reading included only unenhanced images, whereas complete image sets were available for the second reading. RESULTS: Gd contrast injection appeared unimportant to MRI scores of bone erosions and bone edema in RA wrist and MCP joints. However, when post-Gd MRI was considered the standard reference, MRI without Gd provided only moderate to high agreement concerning assessment of synovitis, and omitting the post-Gd acquisitions increased the interreader variation on synovitis scores. Low-field (0.2 T) E-MRI in these exercises provided a lower sensitivity of unenhanced imaging for synovitis than MRI using higher-field strengths. CONCLUSION: Omitting IV contrast injection did not change scores of bone erosions and bone edema, but decreased the reliability of synovitis scores. However, this disadvantage may for some purposes be outweighed by the possibility to assess more joints and/or greater feasibility.

U2 - 10.3899/jrheum.090350

DO - 10.3899/jrheum.090350

M3 - Journal article

C2 - 19671817

VL - 36

SP - 1806

EP - 1810

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 8

ER -

ID: 20621243